Rabies hondsdolheid speeksel besmet dier

Rabies

Rabies (lyssa) is one of the oldest known zoonotic diseases, meaning that the disease can be transferred from animals to humans. Humans and animals can get rabies through the saliva of infected animals, when bitten, scratched or licked.

The disease is caused by different lyssaviruses (Lyssa is the Greek goddess of madness). These are viruses that can occur in all mammals. The best known is the classic rabies virus. It occurs worldwide in dogs, cats, ferrets, foxes, and other mammals. It is also present in bats on the American continents and some islands in the Caribbean.

The virus is lethal when treatment is not started immediately. Human-to-human transmission of the infection does not occur. Animals that are infected can pass the virus on before they exhibit symptoms themselves.

Spread

The main vectors of the disease worldwide are mostly carnivores (dogs, cats, foxes, monkeys, and bats). It is not always apparent when an animal is infected with rabies; bats in particular do not visibly suffer from the virus. In general, it is suspicious when an animal is aggressive, restless, or simply behaving unnaturally. In the Netherlands, bats form the main reservoir of the disease, although exposure through imported animals/pets is always a potential risk.

Virus

The rabies virus (see figure 1) is a negative-sense single-stranded RNA virus with a distinct bullet shape, which belongs to the order Mononegavirales, family Rhabdoviridae (rhabdo=bullet), genus lyssavirus. Of the lyssavirus genus, 16 genotypes are currently known (table 1). Only genotype 2 has never been found in humans.

Figure 1: Rabiësvirus (source: ATV's Special Rabies page by Steven K. Vernon) Figure 1: Rabiësvirus (source: ATV's Special Rabies page by Steven K. Vernon)
Table 1
Table 1

Which animals can get infected with rabies in the Netherlands?

The Netherlands is free of the classic rabies virus. In 1987, two related lyssaviruses were found in bats in the Netherlands for the first time. They are both called the European Bat Lyssavirus (EBLV), which is differentiated into two types, namely type 1 (EBLV-1) and type 2 (EBLV-2). EBLV-1 is found regularly in serotine bats (Eptesicus serotinus) in the Netherlands and other European countries. Research has shown that EBLV-1 is present on average in 22% of the sick, weak, or dead serotine bats found in the Netherlands. It is therefore easy for people and pets, usually cats, to come into contact with these animals. We assume this percentage to be significantly lower in populations with ordinary living conditions. EBLV-2 was found a few times in Netherlands in pond bats (Myotis dasycneme), but in other European countries, this type of virus is especially found in the Daubenton's bat (Myotis daubentonii). Several Natterer’s bats (Myotis nattereri) with the Bokeloh Bat Lyssavirus (BBLV) were discovered in Germany and France. The Lleida Bat Lyssavirus (LBLV) was found in Schreiber's bats (Miniopterus schreibersii), a species that occurs elsewhere in Europe, but not in the Netherlands.

It should always be taken into consideration that any type of bat may be a lyssavirus carrier.

Further reading:

Bat rabies and the risk for people

You can only contract an EBLV infection by direct contact with an infected bat. This requires a bite, scratch, or saliva from the infected bat coming into contact with the eyes, nose, mouth, or an open wound. You cannot contract rabies by being in the same space or building as a bat. Bats in wall cavities do not pose a danger to people.

What are the risk groups in connection with bat rabies?

In Europe, only a few fatal cases of EBLV in people are known. Anyone who, professionally or voluntarily, comes into direct contact with bats is at risk. A schedule of vaccinations and titre controls was developed for those who are possibly exposed to EBLV regularly.

Incubation period

After a bite from an infected animal or caring for a rabid person, the saliva with the rabies virus can end up in the subcutaneous tissue or in the muscles. It is believed that the virus multiplies in the muscle cells, and once the concentration is high enough, it invades the nervous system. The incubation period in humans is on average 20 to 60 days, but it can be over a year. This mainly depends on the place where you get bitten; the further from the central nervous system, the longer the incubation period. The species that delivered the bite, the nature of the bite, and the amount of virus also determine the incubation period.

Symptoms

The symptoms of rabies are, especially in the first (prodromal) phase, quite variable and usually start fairly non-specifically, with a slight fever, general malaise, headache, decreased appetite, sore throat, and nausea. The site of the wound may be itchy and painful, which may be a result of the virus multiplying in the sensory nerves.

During the neurological phase, symptoms emerge such as hyperactivity, stiffness of the neck, convulsions, and signs of paralysis, especially in the wound area. In about half of patients, aerophobia or hydrophobia occurs. Feeling air or seeing liquid triggers spasms of the breathing and swallowing muscles, which are so unpleasant that the patient becomes afraid of water.

Eradication in developing countries

Despite the fact that Louis Pasteur developed an effective vaccine against rabies in 1885, this zoonotic illness is still a major public health problem in developing countries. According to figures from the World Health Organization (WHO), more than 59,000 people die each year of rabies and about 10 million people receive medical treatment after exposure to the disease. The WHO launched a strategic vision in 2017 which aims for zero deadly cases of dog-related rabies before 2030!

Eradication in Europe

Since the Middle Ages, most Western European countries have introduced measures such as dog taxes to combat the nuisance of stray dogs, and with it the spread of rabies. The disease occurs almost exclusively in foxes in continental Western Europe today. The Netherlands and Belgium completely eliminated classical rabies by oral vaccination of foxes and other wildlife, using baits with a modified rabies virus stem which immunised the animals. This method was developed about 25 years ago and has produced excellent results since. The annual number of rabies cases in Europe has fallen from 21,000 in 1990 to 5,400 in 2004. Several countries have since been officially declared rabies free.

Publications